{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:37:09Z","timestamp":1788827829808,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clon.2025.103995","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:10:49Z","timestamp":1764979849000},"page":"103995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Stereotactic Body Radiotherapy for Extracranial Oligometastatic Pancreatobiliary Cancer"],"prefix":"10.1016","volume":"49","author":[{"given":"A.N.","family":"Mian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Myrehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0103-3591","authenticated-orcid":false,"given":"S.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Taggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4694-3659","authenticated-orcid":false,"given":"S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-6070","authenticated-orcid":false,"given":"L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-5406","authenticated-orcid":false,"given":"H.T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2025.103995_bib1","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial","volume":"38","author":"Palma","year":"2020","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study","volume":"37","author":"Gomez","year":"2019","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial","volume":"36","author":"Ost","year":"2018","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2025.103995_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.eururo.2021.07.026","article-title":"Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study","volume":"80","author":"Cheung","year":"2021","journal-title":"European Urology"},{"key":"10.1016\/j.clon.2025.103995_bib8","article-title":"Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial","author":"Ludmir","year":"2024","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib9","first-page":"142","article-title":"Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter","author":"Thompson","year":"2020","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2021.06.012","article-title":"Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters","volume":"161","author":"Tan","year":"2021","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2018.08.005","article-title":"Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?","volume":"124","author":"Merino Lara","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2025.103995_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jmir.2013.04.002","article-title":"Stereotactic Body Radiotherapy for the Treatment of Spinal Metastases: An Overview of the University of Toronto, Sunnybrook Health Sciences Odette Cancer Centre, Technique","volume":"44","author":"Sangha","year":"2013","journal-title":"Journal of Medical Imaging and Radiation Sciences"},{"key":"10.1016\/j.clon.2025.103995_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2021.09.004","article-title":"International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases","volume":"112","author":"Nguyen","year":"2022","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.clon.2025.103995_bib14","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190627","article-title":"Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question","volume":"93","author":"Scorsetti","year":"2020","journal-title":"The British Journal of Radiology"},{"key":"10.1016\/j.clon.2025.103995_bib15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MPA.0000000000001822","article-title":"Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective Study","volume":"50","author":"Lee","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.clon.2025.103995_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2022.07.019","article-title":"Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes","volume":"114","author":"Elamir","year":"2022","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.clon.2025.103995_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib18","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1245\/s10434-020-08207-0","article-title":"Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis","volume":"27","author":"Morino","year":"2020","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib19","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00432-020-03285-9","article-title":"Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity","volume":"146","author":"Franzese","year":"2020","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ijrobp.2022.08.027","article-title":"Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials","volume":"114","author":"Kim","year":"2022","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.clon.2025.103995_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamaoncol.2020.6146","article-title":"Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer: A Systematic Review and Meta-analysis","volume":"7","author":"Lehrer","year":"2021","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.clon.2025.103995_bib22","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: A Cancer Journal for Clinicians"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552500250X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552500250X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T20:15:48Z","timestamp":1768853748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093665552500250X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"alternative-id":["S093665552500250X"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.103995","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Body Radiotherapy for Extracranial Oligometastatic Pancreatobiliary Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.103995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"103995"}}